{"DataElement":{"publicId":"7332103","version":"1","preferredName":"Tumor Mass Cervical Neoplasm Histologic Type","preferredDefinition":"The type of tissue in which a malignant neoplasm involving the cervix originated.","longName":"6796606v1.0:7332089v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6796606","version":"1","preferredName":"Tumor Mass Histologic Type","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._Refers to the type of tissue in which a tumor originated.","longName":"4976411v1.0:2673286v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"4976411","version":"1","preferredName":"Tumor Mass","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","longName":"C98275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DC5FA96-6845-8A34-E050-BB89AD4344BC","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"DAVISJ","dateCreated":"2015-08-20","modifiedBy":"ONEDATA","dateModified":"2015-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2673286","version":"1","preferredName":"Histologic Type","preferredDefinition":"Refers to the type of tissue in which a tumor originated.","longName":"C61478","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3820C878-7530-31CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-20","endDate":null,"createdBy":"UMLLOADER_BCR","dateCreated":"2007-08-20","modifiedBy":"ONEDATA","dateModified":"2007-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8C3F2573-4FAB-6BB5-E053-F662850AE327","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Upd RD to \"Qualified\"; CPTAC released AI. 1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF. 7/26/19 jk Updated OC term to Tumor Mass; used on multiple CPTAC CRFs.  6/26/19 jk created for CPTAC Baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7332089","version":"1","preferredName":"Cervical Neoplasm Histologic Type","preferredDefinition":"A benign or malignant neoplasm that affects the cervix. Representative examples include endocervical polyp, rhabdomyoma, carcinoma, and melanoma._Refers to the type of tissue in which a tumor originated._Something distinguishable as an identifiable class based on common qualities.","longName":"TMR_CESC_HIST_TP","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Adenosquamous Carcinoma","valueDescription":"Cervical Adenosquamous Carcinoma","ValueMeaning":{"publicId":"7332091","version":"1","preferredName":"Cervical Adenosquamous Carcinoma","longName":"7332091","preferredDefinition":"An uncommon carcinoma arising from the cervix.  It is composed of malignant glandular epithelial cells and malignant squamous epithelial cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Adenosquamous Carcinoma","conceptCode":"C4519","definition":"An uncommon carcinoma arising from the cervix.  It is composed of malignant glandular epithelial cells and malignant squamous epithelial cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A826878D-5CB8-4AF5-E053-4EBD850A14F0","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A826878D-5CD1-4AF5-E053-4EBD850A14F0","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":"Cervical Adenocarcinoma","ValueMeaning":{"publicId":"4722591","version":"1","preferredName":"Cervical Adenocarcinoma","longName":"4722591","preferredDefinition":"An adenocarcinoma arising from the cervical epithelium. It accounts for approximately 15% of invasive cervical carcinomas. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors. Grossly, advanced cervical adenocarcinoma may present as an exophytic mass, an ulcerated lesion, or diffuse cervical enlargement. Microscopically, the majority of cervical adenocarcinomas are of the endocervical (mucinous) type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Adenocarcinoma","conceptCode":"C4029","definition":"An adenocarcinoma arising from the endocervical glandular epithelium. It is classified as either human papillomavirus-related or human papillomavirus-independent adenocarcinoma. Histologic variants include usual-type, mucinous, mesonephric, serous, clear cell, and endometrioid adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-BA67-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A826878D-5CE5-4AF5-E053-4EBD850A14F0","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma, Nonkeratinizing","valueDescription":"Cervical Non-Keratinizing Squamous Cell Carcinoma","ValueMeaning":{"publicId":"7332093","version":"1","preferredName":"Cervical Non-Keratinizing Squamous Cell Carcinoma","longName":"7332093","preferredDefinition":"A variant of cervical squamous cell carcinoma characterized by the presence of polygonal squamous cells. Intercellular bridges and cytoplasmic keratinization may be present, but keratin pearls are absent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Non-Keratinizing Squamous Cell Carcinoma","conceptCode":"C40188","definition":"A variant of cervical squamous cell carcinoma characterized by the presence of polygonal squamous cells. Intercellular bridges and cytoplasmic keratinization may be present, but keratin pearls are absent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A826878D-5CF3-4AF5-E053-4EBD850A14F0","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A826878D-5D0C-4AF5-E053-4EBD850A14F0","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma, Keratinizing","valueDescription":"Cervical Keratinizing Squamous Cell Carcinoma","ValueMeaning":{"publicId":"7332095","version":"1","preferredName":"Cervical Keratinizing Squamous Cell Carcinoma","longName":"7332095","preferredDefinition":"A variant of cervical squamous cell carcinoma characterized by the presence of keratin pearls. Intercellular bridges and cytoplasmic keratinization are usually present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Keratinizing Squamous Cell Carcinoma","conceptCode":"C40187","definition":"A variant of cervical squamous cell carcinoma characterized by the presence of keratin pearls. Intercellular bridges and cytoplasmic keratinization are usually present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A826878D-5D19-4AF5-E053-4EBD850A14F0","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A826878D-5D32-4AF5-E053-4EBD850A14F0","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other Histologic Type","ValueMeaning":{"publicId":"7331757","version":"1","preferredName":"Other Histologic Type","longName":"7331757","preferredDefinition":"A selected option that indicated an other histologic type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other Histologic Type","conceptCode":"C159613","definition":"A selected option that indicated an other histologic type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A80C0DF2-F90A-58A8-E053-4EBD850A7EC2","latestVersionIndicator":"Yes","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A826878D-5D3D-4AF5-E053-4EBD850A14F0","beginDate":"2020-06-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7332088","version":"1","preferredName":"Cervical Neoplasm Histologic Type Type","preferredDefinition":"A benign or malignant neoplasm that affects the cervix. Representative examples include endocervical polyp, rhabdomyoma, carcinoma, and melanoma.:Refers to the type of tissue in which a tumor originated.:Something distinguishable as an identifiable class based on common qualities.","longName":"C2940:C61478:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Neoplasm","conceptCode":"C2940","definition":"A benign, malignant, or precancerous neoplasm that affects the cervix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A826878D-5C8F-4AF5-E053-4EBD850A14F0","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A826878D-5CA0-4AF5-E053-4EBD850A14F0","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"KNABLEJ","dateModified":"2020-07-28","changeDescription":"7/28/20 jk Released per SME (NGM) review and approval email.  6/15/20 jk created for CPTAC CESC baseline, local and path report CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6570063","version":"1","longName":"Cervix","context":"OCCPR"},{"publicId":"6779609","version":"1","longName":"CESC Baseline","context":"OCCPR"},{"publicId":"6779610","version":"1","longName":"CESC Local Pathology","context":"OCCPR"},{"publicId":"6779611","version":"1","longName":"CESC Pathology Review","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A825C1DC-B348-4DE2-E053-4EBD850AC776","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"KNABLEJ","dateModified":"2020-07-29","changeDescription":"7/29/20 jk Released per SME (NGM) review and approval email. 6/15/20 jk created for CPTAC CESC baseline, path review and local path CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}